Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wedekind, S. Erster STAMP-Inhibitor bei Patienten mit resistenter CML erfolgreich. Im Fokus Onkologie 24, 45–46 (2021). https://doi.org/10.1007/s15015-021-3372-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15015-021-3372-z